These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18603941)

  • 1. Human papilloma virus and cancer of the cervix: a challenge facing Nepal.
    Gilbert DC
    Kathmandu Univ Med J (KUMJ); 2006; 4(3):396-7. PubMed ID: 18603941
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vaccine against human papillomavirus : PATRICIA Study (PApilloma TRIal against Cancer In young Adults)].
    Kaufmann AM; Nitschmann S
    Internist (Berl); 2010 Mar; 51(3):410, 412-3. PubMed ID: 20127302
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of human papillomavirus vaccine in reducing the risk of cervical cancer in Ireland due to HPV types 16 and 18 using a transmission dynamic model.
    Usher C; Tilson L; Olsen J; Jepsen M; Walsh C; Barry M
    Vaccine; 2008 Oct; 26(44):5654-61. PubMed ID: 18723068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination protects against invasive HPV-associated cancers.
    Luostarinen T; Apter D; Dillner J; Eriksson T; Harjula K; Natunen K; Paavonen J; Pukkala E; Lehtinen M
    Int J Cancer; 2018 May; 142(10):2186-2187. PubMed ID: 29280138
    [No Abstract]   [Full Text] [Related]  

  • 5. [HPV vaccination and cervical cancer screening].
    Sigurdsson K
    Laeknabladid; 2007 Dec; 93(12):819, 821. PubMed ID: 18057470
    [No Abstract]   [Full Text] [Related]  

  • 6. Human papilloma virus vaccines and their role in cancer prevention.
    Jones RW; Coughlan EP; Reid JS; Sykes P; Watson PD; Cook C
    N Z Med J; 2007 Nov; 120(1266):U2829. PubMed ID: 18264198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus-associated diseases in Israel--the controversy continues. Foreword.
    Bornstein J; Shavit O
    Vaccine; 2013 Nov; 31 Suppl 8():vii-x. PubMed ID: 24229722
    [No Abstract]   [Full Text] [Related]  

  • 8. Trends in Genital Warts in the Era of Human Papillomavirus Vaccination.
    Calo WA; Brewer NT
    Sex Transm Dis; 2015 Dec; 42(12):669-70. PubMed ID: 26560967
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment.
    Hildesheim A; Gonzalez P; Kreimer AR; Wacholder S; Schussler J; Rodriguez AC; Porras C; Schiffman M; Sidawy M; Schiller JT; Lowy DR; Herrero R;
    Am J Obstet Gynecol; 2016 Aug; 215(2):212.e1-212.e15. PubMed ID: 26892991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Human papillomavirus (HPV) vaccines--a new method for the prevention of cervical cancer].
    Friedek DA; Ekiel AM; Martirosian G
    Wiad Lek; 2007; 60(1-2):34-8. PubMed ID: 17607966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus vaccine efficacy: aligning expectations with reality.
    Smith-McCune KK
    Gynecol Oncol; 2008 Oct; 111(1):1-2. PubMed ID: 18922296
    [No Abstract]   [Full Text] [Related]  

  • 12. Vaccinating adolescents and young women against cancer of the cervix.
    Hilgers RD; Wyatt SW
    J Ky Med Assoc; 2007 May; 105(5):215-6. PubMed ID: 17566465
    [No Abstract]   [Full Text] [Related]  

  • 13. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of
    Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
    BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK.
    Cuzick J; Castañón A; Sasieni P
    Br J Cancer; 2010 Mar; 102(5):933-9. PubMed ID: 20104226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
    Muñoz N; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia PJ; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Huh WK; Joura EA; Kurman RJ; Majewski S; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Lupinacci LC; Giacoletti KE; Sings HL; James MK; Hesley TM; Barr E; Haupt RM
    J Natl Cancer Inst; 2010 Mar; 102(5):325-39. PubMed ID: 20139221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent high-risk HPV co-infections excluding types 16 or 18 in cervical neoplasia in Guadeloupe.
    Gaete S; Auguste A; Bhakkan B; Peruvien J; Herrmann-Storck C; Socrier Y; Diedhiou A; Deloumeaux J
    BMC Cancer; 2021 Mar; 21(1):281. PubMed ID: 33726684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus vaccines: what does the future hold for preventing cervical cancer in resource-poor settings through immunization programs?
    Jacob M; Bradley J; Barone MA
    Sex Transm Dis; 2005 Oct; 32(10):635-40. PubMed ID: 16205306
    [No Abstract]   [Full Text] [Related]  

  • 18. Population-Based Incidence of Cervical Intraepithelial Neoplasia Across 14 Years of HPV Vaccination.
    Adcock R; Kang H; Castle PE; Kinney W; Emeny RT; Wiggins C; Wheeler CM
    JAMA Oncol; 2024 Sep; 10(9):1287-1290. PubMed ID: 39052303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Swedish consensus on cervix cancer vaccination. Vaccination programs for eradication of HPV16/18 should be initiated in elementary schools].
    Dillner J; Andrae B; Westermark B
    Lakartidningen; 2006 Nov 1-7; 103(44):3377-9. PubMed ID: 17152260
    [No Abstract]   [Full Text] [Related]  

  • 20. Declining rates of cervical intraepithelial neoplasia in British Columbia, Canada: An ecological analysis on the effects of the school-based human papillomavirus vaccination program.
    Donken R; van Niekerk D; Hamm J; Spinelli JJ; Smith L; Sadarangani M; Albert A; Money D; Dobson S; Miller D; Lee M; Mitchell-Foster S; Krajden M; Naus M; Ogilvie G
    Int J Cancer; 2021 Jul; 149(1):191-199. PubMed ID: 33586169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.